共 50 条
- [2] A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients Blood Cancer Journal, 13
- [3] R-CHOP Plus Bortezomib Unpromising in Patients With DLBCL, While an Early Trial of R-CHOP Plus Everolimus Shows Remarkable Results AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 : 9 - 11
- [4] MYC-rearranged lymphomas other than Burkitt: Comparison between R-CHOP and Burldtt-type immunochemotherapy MEDICINA CLINICA, 2017, 149 (08): : 339 - 342
- [5] Lenalidomide in combination with R-CHOP in lymphoma LANCET ONCOLOGY, 2014, 15 (11): : E476 - E476
- [9] CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies BLOOD CANCER JOURNAL, 2018, 8